Trump's Vaccine Plan Brings Obstacles to Parents, Providers, and Drugmakers
(MedPage Today) -- Public health experts have been quick to condemn an executive order from President Donald Trump aimed at upending childhood vaccinations in the U.S., but the biggest obstacles may be the unprecedented financial and logistical...
President Donald Trump's executive order has sparked controversy by proposing to separate combination childhood vaccines, such as the MMR, into individual shots. Public health experts, however, argue that this change would create significant financial and logistical challenges for parents, healthcare providers, and drug manufacturers.
The order instructs federal officials to develop plans for unbundling the MMR vaccine and spacing out other vaccinations within 90 days. Critics warn that this would force drugmakers to revive individual vaccines that have not been marketed separately in the U.S. for decades, requiring new manufacturing plants and extensive studies.
Parents would be required to visit doctors more frequently, potentially straining pediatricians and increasing costs. Health experts maintain that there is no scientific basis for breaking up combination vaccines, emphasizing the importance of convenience and cost-effectiveness in public health measures.
Written by urgent.news from MedPage Today's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
